Skip to main content
. 2020 Dec 24;13:13225–13236. doi: 10.2147/OTT.S278755

Table 2.

RBM38 and Tumors

Expression Tumor Function References
Low Breast cancer RBM38 acts as a tumor suppressor by reducing c-Myc and enhancing PTEN expression. It participates in the tumorigenesis process by decreasing the ability of p53 to activate its target genes and regulate the expression of ER and PR. [14,19,22]
Low HCC RBM38 restores the stability of the p53-mdm2 loop. [16,64]
High Lung cancer RBM38 promotes lung cancer by inhibiting the translation of p53. [65]
Low Gastric cancer The details need further research. [23]
Low AML RBM38 stabilizes P21CIP1 to suppress AML. [20]
High Lymph cancer RBM38 plays a role in lymphomagenesis by inactivating p53. [24]
Low Renal carcinoma RBM38 binds to and stabilizes p21 mRNA, thereby inducing cell cycle arrest in the G1 phase. [21]